Henri Rochefort
#120,628
Most Influential Person Now
Henri Rochefort's AcademicInfluence.com Rankings
Henri Rochefortbiology Degrees
Biology
#7292
World Rank
#10189
Historical Rank
Cell Biology
#262
World Rank
#270
Historical Rank
Genetics
#689
World Rank
#776
Historical Rank
Molecular Biology
#829
World Rank
#850
Historical Rank
Download Badge
Biology
Henri Rochefort's Degrees
- PhD Molecular Biology Université Paris Cité
Why Is Henri Rochefort Influential?
(Suggest an Edit or Addition)Henri Rochefort's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Decreased expression of estrogen receptor beta protein in proliferative preinvasive mammary tumors. (2001) (527)
- A secreted glycoprotein induced by estrogen in human breast cancer cell lines (1980) (496)
- The Lancet: saturday 11 November 1989 (1989) (463)
- Tamoxifen and metabolites in MCF7 cells: correlation between binding to estrogen receptor and inhibition of cell growth. (1982) (420)
- Steroid hormone receptors. (1975) (335)
- Cathepsin D: newly discovered functions of a long-standing aspartic protease in cancer and apoptosis. (2006) (333)
- CATHEPSIN D: AN INDEPENDENT PROGNOSTIC FACTOR FOR METASTASIS OF BREAST CANCER (1989) (319)
- Autocrine growth stimulation of the MCF 7 breast cancer cells by the estrogen-regulated 52 K protein. (1986) (303)
- In vitro degradation of extracellular matrix with Mr 52,000 cathepsin D secreted by breast cancer cells. (1988) (251)
- Association between high concentrations of Mr 52,000 cathepsin D and poor prognosis in primary human breast cancer. (1989) (249)
- Hydroxylated metabolites of tamoxifen are formed in vivo and bound to estrogen receptor in target tissues. (1981) (241)
- Increased secretion, altered processing, and glycosylation of pro-cathepsin D in human mammary cancer cells. (1989) (235)
- Estrogen‐induced lysosomal proteases secreted by breast cancer cells: A role in carcinogenesis? (1987) (216)
- Antiestrogens inhibit the mitogenic effect of growth factors on breast cancer cells in the total absence of estrogens. (1987) (210)
- Differential Expression of Estrogen Receptor-α and -β Messenger RNAs as a Potential Marker of Ovarian Carcinogenesis (1998) (201)
- Estrogens stimulate cell proliferation and induce secretory proteins in a human breast cancer cell line (T47D). (1982) (189)
- Steroid receptor-mediated cytotoxicity of an antiestrogen and an antiprogestin in breast cancer cells. (1987) (188)
- Activation of estrogen receptor transfected into a receptor-negative breast cancer cell line decreases the metastatic and invasive potential of the cells. (1992) (187)
- Overexpression of transfected cathepsin D in transformed cells increases their malignant phenotype and metastatic potency. (1990) (187)
- Regulation of cathepsin-D and pS2 gene expression by growth factors in MCF7 human breast cancer cells. (1989) (182)
- Effects of plasma estrogen sulfates in mammary cancer cells. (1980) (181)
- Antiestrogenic effect of R5020, a synthetic progestin in human breast cancer cells in culture. (1983) (176)
- Estradiol increases and anti-estrogens antagonize the growth factor-induced activator protein-1 activity in MCF7 breast cancer cells without affecting c-fos and c-jun synthesis. (1993) (171)
- Overexpression of p21WAF1/CIP1 induces growth arrest, giant cell formation and apoptosis in human breast carcinoma cell lines. (1995) (167)
- Characterization of very acidic phagosomes in breast cancer cells and their association with invasion. (1994) (165)
- Breast cancer cells have a high capacity to acidify extracellular milieu by a dual mechanism (1997) (157)
- Cathepsin D in breast cancer: a tissue marker associated with metastasis. (1992) (154)
- Cathepsin D in breast cancer: mechanisms and clinical applications, a 1999 overview. (2000) (153)
- Phosphorylation, glycosylation, and proteolytic activity of the 52-kD estrogen-induced protein secreted by MCF7 cells (1987) (152)
- RU486, a progestin and glucocorticoid antagonist, inhibits the growth of breast cancer cells via the progesterone receptor. (1985) (152)
- Estrogen Receptor β (ERβ) Level but Not Its ERβcx Variant Helps to Predict Tamoxifen Resistance in Breast Cancer (2004) (148)
- MCF7 mammary cancer cells respond to bFGF and internalize it following its release from extracellular matrix: a permissive role of cathepsin D. (1991) (147)
- Biological and Clinical Significance of Cathepsin D in Breast Cancer Metastasis (1996) (144)
- Cathepsin D gene is controlled by a mixed promoter, and estrogens stimulate only TATA-dependent transcription in breast cancer cells. (1993) (143)
- Interactions of cathepsin-D and insulin-like growth factor-II (IGF-II) on the IGF-II/mannose-6-phosphate receptor in human breast cancer cells and possible consequences on mitogenic activity of IGF-II. (1990) (138)
- Characterization of the proximal estrogen-responsive element of human cathepsin D gene. (1994) (132)
- Cathepsin D in breast cancer cells can digest extracellular matrix in large acidic vesicles. (1990) (132)
- Estrogenic Effects of Physiological Concentrations of 5-Androstene-3β,17β-diol and Its Metabolism in MCF7 Human Breast Cancer Cells (1981) (130)
- Biological and clinical significance of cathepsin D in breast cancer. (1990) (125)
- Estrogens and growth factors induce the mRNA of the 52K-pro-cathepsin-D secreted by breast cancer cells. (1988) (125)
- Cathepsin D in cancer metastasis: A protease and a ligand (1999) (120)
- A mutated cathepsin-D devoid of its catalytic activity stimulates the growth of cancer cells (2001) (120)
- Down-regulation of cathepsin-D expression by antisense gene transfer inhibits tumor growth and experimental lung metastasis of human breast cancer cells (2002) (120)
- Effect of estradiol on the ultrastructure of the MCF7 human breast cancer cells in culture. (1982) (118)
- Retinoid-resistant estrogen receptor-negative human breast carcinoma cells transfected with retinoic acid receptor-alpha acquire sensitivity to growth inhibition by retinoids. (1994) (114)
- Formation of estrogen nuclear receptor in uterus: effect of androgens, estrone and nafoxidine. (1972) (110)
- Effects of antiestrogens on the estrogen-regulated pS2 RNA and the 52- and 160-kilodalton proteins in MCF7 cells and two tamoxifen-resistant sublines. (1984) (108)
- Differential expression of estrogen receptor-alpha and -beta messenger RNAs as a potential marker of ovarian carcinogenesis. (1998) (108)
- How to target estrogen receptor-negative breast cancer? (2003) (107)
- Estrogen induction and overexpression of fibulin-1C mRNA in ovarian cancer cells (2002) (105)
- Estradiol and fibulin‐1 inhibit motility of human ovarian‐ and breast‐cancer cells induced by fibronectin (1998) (105)
- Differences between oestrogen receptor activation by oestrogen and antioestrogen (1981) (105)
- Metabolism and protein binding of sex steroids in target organs: an approach to the mechanism of hormone action. (1971) (104)
- Differential Interaction of Nuclear Receptors with the Putative Human Transcriptional Coactivator hTIF1* (1997) (103)
- The 52-kDa estrogen-induced protein secreted by MCF7 cells is a lysosomal acidic protease. (1986) (103)
- High-affinity binding to the estrogen receptor of [3H]4-hydroxytamoxifen, an active antiestrogen metabolite (1980) (103)
- Androgen on the estrogen receptor I — Binding and in vivo nuclear translocation (1976) (98)
- The estrogenic and antiestrogenic activities of androgens in female target tissues. (1983) (98)
- The antiprogestin RU486 in advanced breast cancer: preliminary clinical trial. (1986) (97)
- Estradiol down-regulates the mannose-6-phosphate/insulin-like growth factor-II receptor gene and induces cathepsin-D in breast cancer cells: a receptor saturation mechanism to increase the secretion of lysosomal proenzymes. (1991) (95)
- Estradiol induced proteins in the MCF7 human breast cancer cell line. (1979) (95)
- Regulation of estrogen receptors in ovarian-dependent rat mammary tumors. I. Effects of castration and prolactin. (1976) (94)
- Characterization of monoclonal antibodies to the estrogen-regulated Mr 52,000 glycoprotein and their use in MCF7 cells. (1985) (93)
- Cathepsin D assay in primary breast cancer and lymph nodes: relationship with c-myc, c-erb-B-2 and int-2 oncogene amplification and node invasiveness. (1990) (92)
- Why are estrogen-receptor-negative breast cancers more aggressive than the estrogen-receptor-positive breast cancers? (1994) (91)
- Cloning and sequencing of the 52K cathepsin D complementary deoxyribonucleic acid of MCF7 breast cancer cells and mapping on chromosome 11. (1988) (88)
- Estradiol stimulates cell growth and secretion of procathepsin D and a 120-kilodalton protein in the human ovarian cancer cell line BG-1. (1992) (88)
- Unliganded and liganded estrogen receptors protect against cancer invasion via different mechanisms. (2000) (84)
- Synthetic antiestrogens modulate induction of pS2 and cathepsin-D messenger ribonucleic acid by growth factors and adenosine 3',5'-monophosphate in MCF7 cells. (1993) (84)
- SKOV3 ovarian carcinoma cells have functional estrogen receptor but are growth-resistant to estrogen and antiestrogens (1995) (83)
- Estrogen receptor beta (ER beta) level but not its ER beta cx variant helps to predict tamoxifen resistance in breast cancer. (2004) (82)
- FRA-1 expression level modulates regulation of activator protein-1 activity by estradiol in breast cancer cells. (1998) (82)
- Evidence and characterization of the binding of two 3H-labeled androgens to the estrogen receptor. (1979) (80)
- Estrogens increase the expression of fibulin-1, an extracellular matrix protein secreted by human ovarian cancer cells. (1996) (79)
- Overexpression and hormonal regulation of pro-cathepsin D in mammary and endometrial cancer. (1989) (78)
- Mechanisms of 4-hydroxytamoxifen anti-growth factor activity in breast cancer cells: alterations of growth factor receptor binding sites and tyrosine kinase activity. (1990) (76)
- Cathepsin D immunostaining in paraffin-embedded breast cancer cells and macrophages: correlation with cytosolic assay. (1994) (75)
- Transfected cathepsin D stimulates high density cancer cell growth by inactivating secreted growth inhibitors. (1995) (75)
- Effect of androgen mediated by the estrogen receptor of fish liver: Vitellogenin accumulation (1980) (74)
- Cathepsin D maturation and its stimulatory effect on metastasis are prevented by addition of KDEL retention signal. (1994) (74)
- Specific mannose-6-phosphate receptor-independent sorting of pro-cathepsin D in breast cancer cells. (1994) (74)
- Decrease of c-erbB-2 and c-myc RNA levels in tamoxifen-treated breast cancer. (1991) (73)
- The antiproliferative effect of tamoxifen in breast cancer cells: mediation by the estrogen receptor (1984) (72)
- Dual effects of the progestin R5020 on proteins released by the T47D human breast cancer cells. (1984) (72)
- Fatty acid synthetase and its mRNA are induced by progestins in breast cancer cells. (1987) (72)
- Identification and androgen regulation of two proteins released by T47D human breast cancer cells. (1987) (69)
- Expression of human sequences related to those of mouse mammary tumor virus (1988) (69)
- Cathepsin D: A protease involved in breast cancer metastasis (1990) (66)
- Increased Estrogen Receptor βcx Expression during Mammary Carcinogenesis (2005) (65)
- Cathepsin-D in human endometrium: induction by progesterone and potential value as a tumor marker. (1990) (64)
- In vivo effect of anti-estrogens on the localisation and replenishment of estrogen receptor (1975) (62)
- Processing and estrogen regulation of the 52-kilodalton protein inside MCF7 breast cancer cells. (1986) (61)
- Missense polymorphism (C/T224) in the human cathepsin D pro-fragment determined by polymerase chain reaction--single strand conformational polymorphism analysis and possible consequences in cancer cells. (1994) (60)
- Cathepsin D in breast cancer: from molecular and cellular biology to clinical applications. (1990) (59)
- Anti-steroidal and anti-growth factor activities of anti-estrogens (1990) (58)
- Androgens on the estrogen receptor II — correlation between nuclear translocation and uterine protein synthesis (1977) (58)
- Endocytosis of pro-cathepsin D into breast cancer cells is mostly independent of mannose-6-phosphate receptors. (1998) (57)
- High-affinity binding of the antiestrogen [3H]tamoxifen to the 8S estradiol receptor (1978) (57)
- Cathepsin D concentration in breast cancer cytosols: correlation with biochemical, histological, and clinical findings. (1991) (57)
- Chromatin structure of the regulatory regions of pS2 and cathepsin D genes in hormone-dependent and -independent breast cancer cell lines (1999) (55)
- Structure, function, regulation and clinical significance of the 52K pro-cathepsin D secreted by breast cancer cells. (1988) (55)
- Increased expression of fatty acid synthase and progesterone receptor in early steps of human mammary carcinogenesis (2007) (54)
- Effect of KCl, CaCl2, tempcrature and œstradiol on the uterine cytosol receptor of œstradiol (1971) (53)
- Increased immunostaining of fibulin-1, an estrogen-regulated protein in the stroma of human ovarian epithelial tumors. (1998) (53)
- Immunohistochemical detection of the estrogen-regulated 52,000 mol wt protein in primary breast cancers but not in normal breast and uterus. (1984) (50)
- Inhibition of breast cancer growth by suramin. (1992) (50)
- Dissociated overexpression of cathepsin D and estrogen receptor alpha in preinvasive mammary tumors. (2000) (50)
- Differential regulation of cathepsin D by sex steroids in mammary cancer and uterine cells (1989) (50)
- Cellular and molecular mechanism of action of antiestrogens. (1983) (49)
- Mouse mammary tumour virus related sequences are present in human DNA. (1983) (49)
- Stable transfection of the estrogen receptor cDNA into Hela cells induces estrogen responsiveness of endogenous cathepsin D gene but not of cell growth. (1990) (48)
- Release of estrogen-induced glycoprotein with a molecular weight of 52,000 by breast cancer cells in primary culture. (1983) (47)
- Autocrine stimulation by estradiol-regulated growth factors of rat hormone-responsive mammary cancer: interaction with the polyamine pathway. (1986) (47)
- Hormonal Carcinogenesis V (1996) (47)
- Alterations and role of human cathepsin D in cancer metastasis. (1996) (45)
- New in vitro studies of estradiol binding in castrated rat uterus. (1969) (43)
- Absence of correlation between antiestrogenic activity and binding affinity for the estrogen receptor. (1979) (43)
- Cathepsin D gene of human MCF7 cells contains estrogen-responsive sequences in its 5' proximal flanking region. (1991) (42)
- Estrogen regulated proteases and antiproteases in ovarian and breast cancer cells (2001) (42)
- Progestin increases gene transcription and messenger ribonucleic acid stability of fatty acid synthetase in breast cancer cells. (1989) (42)
- Oestrogen- and anti-oestrogen-regulated genes in human breast cancer. (1995) (38)
- Two-site immunoenzymometric assay for the 52-kDa cathepsin D in cytosols of breast cancer tissues. (1989) (38)
- Binding properties of an anti‐estrogen to the estradiol receptor of uterine cytosol (1972) (37)
- Genomic cross-talk between the estrogen receptor and growth factor regulatory pathways in estrogen target tissues. (1994) (37)
- Immunostaining of cathepsin D in breast cancer: quantification by computerised image analysis and correlation with cytosolic assay. (1992) (37)
- Immunoradiometric assay of pro-cathepsin D in breast cancer cytosol: relative prognostic value versus total cathepsin D. (1993) (36)
- A 250-kilodalton cellular protein is induced by progestins in two human breast cancer cell lines MCF7 and T47D. (1984) (36)
- Estrogen receptor: Loss of DNA binding ability following trypsin or Ca2+ treatment (1973) (36)
- In vitro binding of the estrogen receptor to DNA: Absence of saturation at equilibrium (1975) (35)
- Early effect of estrogen on chromatin ultrastructure in endometrial nuclei (1980) (35)
- Hormonal regulation of cathepsin D following transfection of the estrogen or progesterone receptor into three sex steroid hormone resistant cancer cell lines (1991) (34)
- Cloning of cDNA sequences of a progestin-regulated mRNA from MCF7 human breast cancer cells. (1986) (34)
- Do antiestrogens and antiprogestins act as hormone antagonists or receptor-targeted drugs in breast cancer? (1987) (33)
- Cathepsin D concentration in breast cancer cytosols: correlation with disease-free interval and overall survival. (1992) (33)
- Cathepsin D, both a prognostic factor and a predictive factor for the effect of adjuvant tamoxifen in breast cancer. South Sweden Breast Cancer Group. (1994) (32)
- Progestin-induced fatty acid synthetase in human mammary tumors: From molecular to clinical studies (1992) (32)
- Purification and first characterization of the secreted and cellular 52-kDa proteins regulated by estrogens in human-breast cancer cells. (1986) (32)
- A monoclonal antibody to the estrogen receptor discriminates between the nonactivated and activated estrogen- and anti-estrogen-receptor complexes. (1984) (31)
- Procathepsin D interacts with prosaposin in cancer cells but its internalization is not mediated by LDL receptor-related protein. (2002) (31)
- Progestins and androgens stimulate lipid accumulation in T47D breast cancer cells via their own receptors. (1989) (31)
- Inhibition of estrogen-receptor-DNA interaction by intercalating drugs. (1976) (30)
- Differences between the estradiol and testosterone receptors in rat uterus. (1974) (30)
- [How to reduce the incidence of breast cancer]. (2008) (30)
- Expression of the progestin-induced fatty acid synthetase in benign mastopathies and breast cancer as measured by RNA in situ hybridization. (1990) (30)
- Mannose-6-phosphate/insulin-like growth factor-II receptor expression levels during the progression from normal human mammary tissue to invasive breast carcinomas. (2003) (29)
- Cathepsin D in breast cancer (1990) (29)
- Androgen effects mediated by estrogen receptor in 7,12-dimethylbenz(a)anthracene-induced rat mammary tumors. (1978) (29)
- Characterization of the estradiol receptor extracted from nuclei by micrococcal nuclease. (1978) (28)
- Estradiol dependent decrease of binding inhibition by anti-estrogens (a possible test of receptor activation). (1977) (28)
- Synthesis and Biological Activity of Phosphonate Analogs of Mannose 6‐Phosphate (M6P) (1999) (28)
- Effect of estrogen in breast cancer cells in culture: released proteins and control of cell proliferation. (1984) (27)
- Effect of antiestrogens on uterine estradiol receptors. (1972) (27)
- Estradiol increases the production of α1-antichymotrypsin in MCF7 and T47D human breast cancer cell lines (1985) (26)
- Steroidal and non steroidal antiestrogens in breast cancer cells in culture (1984) (26)
- Biological and clinical significance of cathepsin D in breast cancer. (1990) (26)
- Induction of two estrogen-responsive proteins by antiestrogens in R27, a tamoxifen-resistant clone of MCF7 cells. (1984) (26)
- Stable amino‐acid sequence of the Mannose‐6‐phosphate/insulin‐like growth‐factor‐II receptor in ovarian carcinomas with loss of heterozygosity and in breast‐cancer cell lines (2000) (25)
- Oestrogens, proteases and breast cancer. From cell lines to clinical applications. (1994) (25)
- Effect of Estradiol on Nonmalignant Human Mammary Cells in Primary Culture a (1984) (25)
- Endocrine disruptors (EDs) and hormone-dependent cancers: Correlation or causal relationship? (2017) (25)
- Regulation of fatty acid synthetase ribonucleic acid in the human endometrium during the menstrual cycle. (1990) (24)
- Increased plasma cathepsin D concentration in hepatic carcinoma and cirrhosis but not in breast cancer. (1991) (24)
- Effects of progestins and menstrual cycle on fatty acid synthetase and progesterone receptor in human mammary glands. (1990) (24)
- Specific effect of estrogens on an interaction between the uterine estradiol receptor and DNA (1973) (24)
- Correlation between mannose-6-phosphate/IGFII receptor and cathepsin D RNA levels by in situ hybridization in benign and malignant mammary tumors. (1993) (23)
- A protease involved in breast cancer metastasis. (1990) (23)
- In vitro and in vivo interactions of [3H]dimethylstilbestrol with the estrogen receptor (1977) (23)
- Characterization and properties of two monoclonal antibodies specific for the Mr 52,000 precursor of cathepsin D in human breast cancer cells. (1988) (23)
- Cathepsin D stimulates the activities of secreted plasminogen activators in the breast cancer acidic environment. (2013) (22)
- Progestin-specific markers in human cell lines: biological and pharmacological applications (1984) (22)
- The prognostic value of cathepsin D in breast cancer. A long road to the clinic. (1996) (22)
- Insulin-like growth factors (IGFs) stimulate the release of alpha 1-antichymotrypsin and soluble IGF-II/mannose 6-phosphate receptor from MCF7 breast cancer cells. (1995) (21)
- Antibodies to the estrogen induced 52 K protein released by human breast cancer cells. (1982) (20)
- Nuclear translocation of the estrogen receptor in autonomous C3H mouse mammary tumors. (1978) (20)
- Cellular localisation byin situ hybridisation of cathepsin D, stromelysin 3, and urokinase plasminogen activator RNAs in breast cancer (2005) (20)
- Oestradiol "neo nuclear receptor" in the rat uterus: sedimentation constant and conditions of formation. (1972) (19)
- A monoclonal antibody to the estrogen receptor inhibits in vitro criteria of receptor activation by an estrogen and an anti-estrogen. (1985) (19)
- Mechanism of action of antiestrogens and androgens on the estrogen receptor. (1979) (19)
- Effect of antibodies to estrogen receptor on the binding of 3H-labeled antiestrogens and androstanediol in the uterus. (1982) (19)
- Evidence of androgen and estrogen receptors in the preen gland of male ducks (1977) (19)
- [Estrogen-induced genes in breast cancer, and their medical importance]. (1999) (18)
- Ellipticine derivatives with an affinity to the estrogen receptor, an approach to develop intercalating drugs with a specific effect on the hormone-dependent breast cancer. (1985) (18)
- The anti-progestin RU486 stabilizes the progestin-induced fatty acid synthetase mRNA but does not stimulate its transcription. (1991) (18)
- Cathepsin D cytosolic assay and immunohistochemical quantification in human prostate tumors (1994) (17)
- Immunodetection of estrogen receptor and 52,000-dalton protein in fine needle aspirates of breast cancer tumors. (1987) (17)
- Estradiol increases the secretion by MCF7 cells of several lysosomal pro-enzymes. (1990) (17)
- Mode of action of LN 1643 (a triphenylbromoethylene antiestrogen): probable mediation by the estrogen receptor and high affinity metabolite. (1982) (17)
- Potential value of increased MYC but not ERBB2 RNA levels as a marker of high-risk mastopathies. (1993) (16)
- Both estradiol and tamoxifen decrease proliferation and invasiveness of cancer cells transfected with a mutated estrogen receptor (1997) (16)
- A cytosol protease from the estrogen-resistant C3H mammary carcinoma increases the affinity of the estrogen receptor for DNA in vitro. (1985) (15)
- Interactions of pro-cathepsin D and IGF-II on the mannose-6-phosphate / IGF-II receptor (2005) (15)
- Increased DNA binding of the estrogen receptor in an estrogen-resistant mammary cancer. (1983) (15)
- Biochemical basis of breast cancer treatment by androgens and progestins. (1984) (15)
- [Estrogen-induced proteins secreted by MCF7 human breast cancer cells stimulate their proliferation]. (1983) (14)
- Estrogen-Regulated Proteins and Autocrine Control of Cell Growth in Breast Cancer (1986) (14)
- Nonsteroidal antiestrogens are estrogen-receptor-targeted growth inhibitors that can act in the absence of estrogens. (1987) (14)
- Retinoid regulation of human cathepsin D gene expression (1996) (13)
- Time at surgery during menstrual cycle and menopause affects pS2 but not cathepsin D levels in breast cancer (1999) (13)
- A 5IK Progestin-Regulated Protein Secreted by Human Endometrial Cells in Primary Culture* (1987) (13)
- Difference between R5020 and the antiprogestin RU486 in antiproliferative effects on human breast cancer cells (2005) (13)
- 5-Bromodeoxyuridine specifically inhibits the synthesis of estrogen-induced proteins in MCF7 cells. (1981) (13)
- Nuclear translocation of the estradiol receptor: partial inhibition by ethidium bromide (1977) (13)
- The Role of Sex Steroid Receptors on Lipogenesis in Breast and Prostate Carcinogenesis: A Viewpoint (2010) (13)
- Mechanism of Action of High‐Affinity Antiestrogens An Overview (1991) (13)
- Estrogenic effects of physiological concentrations of 5-androstene-3 beta, 17 beta-diol and its metabolism in MCF7 human breast cancer cells. (1981) (12)
- A two-site immunoenzymometric assay of 52-kDa pro-cathepsin D, and its use in human breast diseases. (1989) (12)
- 454 Use of hormone responsive cell lines to study the mechanism of action of progestin and antiprogestin (1983) (12)
- Effect of tunicamycin and endoglycosidase H and F on the estrogen regulated 52000-Mr protein secreted by breast cancer cells. (1985) (12)
- [Estrogens, cathepsin D and metastasis in cancers of the breast and ovary: invasion or proliferation?]. (1998) (11)
- Hormonal regulation in two rat mammary cancer cell lines: Glucocorticoid and androgen receptors (1979) (11)
- Computer-aided quantification of RNA levels detected by in situ hybridization of tissue sections. (1991) (11)
- The estrogen-regulated 52K-cathepsin-D in breast cancer: from biology to clinical applications. (1987) (11)
- Regulation of fatty acid synthetase by progesterone in normal and tumoral human mammary glands. (1990) (11)
- The estrogen-regulated 52 K protein and plasminogen activators released by MCF7 cells are different (1984) (10)
- [Pro-cathepsin D can activate in vitro pro-cathepsin B secreted by ovarian cancers]. (1989) (10)
- Comment on ‘Difference between R5020 and the anti progestin RU486 in antiproliferative effects on human breast cancer cells’ (1987) (10)
- Identification of prometalloproteinase-3 as a major protein secreted by human endometrial fibroblasts and inhibited by coculture with trophoblast cells. (1996) (10)
- Oestrogen-induced pro-cathepsin D in breast cancer: from biology to clinical applications (1989) (10)
- Endometrial cathepsin D immunostaining throughout ovulatory and anovulatory menstrual cycles. (1996) (10)
- In vivo stimulation by tamoxifen of cathepsin D RNA level in breast cancer. (1994) (10)
- Steroidal and nonsteroidal antiestrogens in breast cancer cells in culture. (1984) (10)
- The extraction by micrococcal nuclease of glucocorticoid receptors and mouse mammary tumor virus DNA sequences is dissociated. (1980) (10)
- Nuclear translocation and interactions of the estrogen receptor in uterus and mammary tumors. (1980) (9)
- Insensitivity of cathepsin D gene to estradiol in endometrial cells is determined by the sequence of its estrogen responsive element. (1994) (9)
- The 52K cathepsin-D of breast cancer: structure, regulation, function and clinical value. (1988) (9)
- The 52K Estrogen‐Regulated Protein Secreted by Breast Cancer Cells and Its Clinical Potential a (1986) (8)
- AUTOCRINE REGULATION OF BREAST CANCER CELL GROWTH BY ESTROGENINDUCED SECRETED PROTEINS AND PEPTIDES (1987) (8)
- Antiproliferative effect of progestins and antiprogestins in human breast cancer cells (1986) (8)
- Comparison between different forms of estrogen cytosol receptor and the nuclear receptor extracted by micrococcal nuclease. (1978) (8)
- Reassessment of breakpoints in chromosome 11p15. (1993) (7)
- SUBREGIONAL MAPPING OF BWS, CTSD, MYOD1, AND A T-ALL BREAKPOINT IN 11P15 (1989) (6)
- Growth regulation of two rat adenocarcinoma cell lines by dexamethasone and progesterone (2005) (6)
- 17 beta Hydroxysteroid dehydrogenase 1 "pseudogene" is differentially transcribed: still a candidate for the breast-ovarian cancer susceptibility gene (BRCA1). (1994) (6)
- Isopycnic banding in metrizamide of the uterine cytosol and nuclear estradiol receptor (1981) (6)
- Inhibition of cathepsin D by tripeptides containing statine analogs. (1999) (6)
- The 52 K protein: an estrogen regulated marker of cell proliferation in human mammary cells. (1986) (5)
- The potential role of procathepsin D secreted by breast cancer cells in bone resorption (1990) (5)
- CHAPTER 9 – Role of the Estrogen Receptor in Estrogen-Responsive Mammalian Cells (1984) (5)
- Progestin treatment depresses estrogen receptor but not cathepsin D levels in needle aspirates of benign breast disease (1991) (5)
- Pro-Cathepsin D in Human Mammary Cancer Cells Increased Secretion , Altered Processing , and Glycosylation of Updated (2006) (4)
- RU 486: a full progestin antagonist in human breast cancer cell lines. (1985) (4)
- Modulation of an Estrogen-Induced Protein in the MCF7 Human Mammary Cancer Cell (1983) (4)
- Effect of pituitary isografts on the concentration of estrogen and glucocorticoid receptors in C3H mice mammary tumors. (1979) (4)
- Cancer Cathepsin D and Poor Prognosis in Primary Human Breast 52 , 000 r M Association between High Concentrations of Updated (2006) (4)
- [Bisphenol A and hormone-dependent cancers: potential risk and mechanism]. (2013) (4)
- Estrogen-Receptor–DNA Interaction (2005) (4)
- Estradiol Receptors in the Uterus (1971) (4)
- A hormone-regulated pro-cathepsin D secreted by human mammary cancer cells. (1989) (3)
- Studies on oestradiol receptors in uterus. (1969) (3)
- [Incidents and accidents of treatment with disulfiram (antabuse). General review and personal observations]. (1967) (3)
- Evaluation of tissue steroid binding in vitro. (1971) (3)
- A 51K progestin-regulated protein secreted by human endometrial cells in primary culture. (1987) (3)
- Estrogen-induced proteins in human breast cancer cells. (1984) (3)
- Breast cancer: when tumor markers become targets for drugs. (1993) (3)
- [Hormonal regulation in breast cancer from cell lines to patients]. (1994) (3)
- Presurgical radiotherapy decreases the concentrations of estrogen and progesterone receptors in human breast cancer: A 200-patient study (2005) (3)
- International organizing committee (2022) (3)
- Expression of estrogen receptors alpha and beta in early steps of human breast carcinogenesis. (2008) (3)
- Study of the Photoattachment of Estrogen Receptor to the Nuclear Acceptor Sites in Human Breast Cancer Cells * (1980) (2)
- Cathepsin D in Breast Cancer—20 Years Later (2002) (2)
- Detection and Assay of the 52K Estrogen-Regulated Protease in Mammary Tumors (1987) (2)
- [Effects and mechanism of action of antiestrogens in breast cancer]. (1983) (2)
- Sex steroid receptors in human myometrium and fibromyoma (1977) (2)
- [In vivo occupation of estrogen receptors by hydroxylated metabolites of tamoxifen]. (1979) (2)
- [Hormonal carcinogenesis in women: from mechanisms to prevention]. (2008) (2)
- Estrogen-receptor--DNA interaction. Difference between activation by estrogen and antiestrogen. (1982) (2)
- Report of the task force on carcinogenic potential. (1966) (2)
- Response to P.M. Ravdin (BCRT 24:219-226, 1993), “Evaluation of cathepsin D as a prognostic factor in breast cancer” (1993) (2)
- [Endocrine disruptors: are they carcinogens?]. (2010) (2)
- ENDOCYTOSIS OF THE SECRETED PRO‐CATHEPSIN D INTO BREAST CANCER CELLS IS PARTLY INDEPENDENT OF THE MANNOSE‐6‐PHOSPHATE RECEPTORS (1996) (2)
- [Mechanism of the overexpression of the cathepsin D gene in breast cancer and consequences in the metastatic process]. (1991) (2)
- Effect of KCl, CaCl 2 , temperature and oestradiol on the uterine cytosol receptor of oestradiol. (1971) (2)
- Regulation, clinical and biological significance of cathepsin D in breast cancer. (1990) (2)
- Estrogen receptors: physiology and clinical applications. (1974) (2)
- Estrogen-induced Pro-cathepsin D and its Relationship to Breast Cancer Invasion and Metastasis (1990) (1)
- Anti-Growth Factor Activity of Antiestrogens in Human Breast Cancer Cells: A Review (1995) (1)
- 154 Estrogen regulated 52 K protein and control of cell proliferation of human breast cancer cells (1983) (1)
- Hormonal carcinogenesis V. Preface. (2008) (1)
- Progestin-Regulated Genes and Breast Cancer Risk: Good or Bad? (2005) (1)
- CATHEPSIN D AND BREAST CANCER METASTASIS: BIOLOGICAL AND CLINICAL SIGNIFICANCE (1992) (1)
- 128. Comparison of steroid hormone receptors in rat uterus using double labelling (1974) (1)
- Hormonal control of carcinogenesis and tumor progression. (1989) (1)
- [Estrogens and breast cancer: from action mechanisms to clinical applications]. (1995) (1)
- [Significance of cathepsin D in breast cancer]. (1990) (1)
- [ON A CASE OF BOTULINUM POISONING]. (1965) (1)
- [Steroid hormone receptors, present state of knowledge]. (1970) (1)
- Effect of Estradici on Nonmalignant Human Mammary Cells in Primary Culture1 (2006) (1)
- [Glucocorticoid receptors in mammary tumors in PS and C3H mouse strains (author's transl)]. (1977) (1)
- 317 Defective activation of the estrogen receptor by triphenylethylene antiestrogens (1983) (1)
- [Estrogen receptors and breast cancer]. (1994) (0)
- [Hormone receptors: relations between the cytoplasmic 8 S, cytoplasmic 4 S, and nuclear uterine receptors of estradiol]. (1968) (0)
- Synthesis and Biological Activity of Phosphonate Analogues of Mannose 6‐Phosphate (M6P). (1999) (0)
- Estrogen receptors in uterine fibroids (1977) (0)
- AN ESTROGEN INDUCED PROTEASE IN BREAST CANCER: FROM BASIC RESEARCH TO CLINICAL APPLICATIONS (1988) (0)
- [Regulation of estrogen receptors in mammary tumors: effect of prolactin in vivo] (1974) (0)
- Estrogen-Regulated Proteins Secreted by Breast Cancer Cells: The Growth-Associated 52K Protein (1986) (0)
- Mots-clés : Cancer du sein - Hormones - Facteurs génétiques - Facteurs de risque - Prévention - Ménopause - Antiœstrogènes. Keywords: Breast cancer - Hormones - Genes susceptibility - Risk factors - Prevention - Menopause - Antiestrogens. (2008) (0)
- Anti-oestrogens inhibit growth factor action in breast tumour cells (1987) (0)
- Hormone Receptors and Interactions Workshop Summary (1988) (0)
- [Measurement of plasma cortisol through radiocompetition in the insulin stimulation test in children]. (1974) (0)
- Distribution of a cytoplasmic estrogen-induced 52 K protein in human breast tumors and double immunocytostaining with the nuclear estrogen receptor on fine needle aspirates (1986) (0)
- Effect of KCl calcium chloride temperature and oestradiol on the uterine cytosol receptor of oestradiol. (1971) (0)
- [Early effect of estradiol on ultrastructure of chromatin in the endometrium and hormone-dependent mammary tumors]. (1978) (0)
- [Proteins induced by estrogens. Search for new markers of hormone dependence in breast cancers]. (1983) (0)
- Nuclear Oestradiol Binding Proteins in the Uterus (1971) (0)
- Significance of cathepsin D and cathepsin D receptor(s) in breast carcinogenesis (1998) (0)
- [Update on the mechanism of action of synthetic antiestrogens]. (1989) (0)
- Comprar Hormonal Control of Cell Cycle | Melmed, Shlomo | 9783540738541 | Springer (2008) (0)
- [Recent data on the mechanism of action of synthetic antiestrogens]. (1982) (0)
- Comparison between Different Forms of Estrogen Cytosol Receptor and the Nuclear Receptor Extracted by Micrococcal Nuclease 1 (2006) (0)
- New drugs for breast cancer (1993) (0)
- Primary culture of human mammary glands and expression of the secreted 52 K protein (1986) (0)
- Cathepsin D as a marker of breast cancer metastasis (1993) (0)
- Autocrine stimulation of breast cancer cell growth by estrogen regulated protein(s) (1986) (0)
- FRLSVDGRSC EDINECSSSP CSQECANVYG SYQCYCRRGY QLSDVDGVTC 451 EDIDECALPT GGHICSYRCI NIPGSFQCSC PSSGYRLAPN GRNCQDIDEC 501 VTGIHNCSIN ETCFNIQGAF RCLAFECPEN YRRSAATRCE RLPCHENREC 551 SKLPLRITYY HLSFPTNIQA PAVVFRMGPS SAVPGDSMQL AITGGNEEGF 601 FTTRKVSPHS GVVALTKPVP EPRDLLLTVK MDLSRHGTVS SFVAKLFIFV (2005) (0)
- Dissociated efficacy of Tamoxifen to induce estrogen specific mRNA and proteins in MCF cells variants (1984) (0)
- Binding of Estradiol and other Estrogens to Castrated Rat and Prepuberal Sow Endometrium Proteins (1969) (0)
- Characterization of Monoclonal Antibodies to the Estrogen-regulated Mr 52 , 000 Glycoprotein and Their Use in MCF 7 Cells 1 (2006) (0)
- Hormones and Cancer Reviewers (2011) (0)
- Antisteroidal and anti-growth factor activities of antestrogens and antiprogestins (1990) (0)
- Contents (2014) (0)
- Characterization of Monoclonal Antibodies to the Estrogen-regulated Mr 52,000 Glycoprotein and Their Use in MCF7 Cells1 (2006) (0)
- International Congress on Hormonal Steroids and Hormones and Cancer How to target estrogen receptor-negative breast cancer? (2003) (0)
- ELLIPTICINE DERIVATIVES WITH AN AFFINITY TO THE ESTROGEN RECEPTOR. AN APPROACH TO DEVELOP INTERCALATING DRUGS WITH A SPECIFIC EFFECT ON THE HORMONE‐DEPENDENT BREAST CANCER (1985) (0)
- [Monoclonal antibodies and new markers in breast oncology]. (1986) (0)
- [The presence of large acidic vesicles is correlated with in vitro invasive potential of breast cancer cells]. (1993) (0)
- [Regulation of estrogen "receptors" in mammary tumors: action of prolactin in vivo]. (1974) (0)
- Subject Index, Vol. 28, 1987 (1987) (0)
- [Estrogen receptors in uterine fibromyomas]. (1977) (0)
- Potential Marker of Ovarian Carcinogenesis1 (1998) (0)
- Mapping of hormone-, DNA- and antibody-binding domains on the calf uterine estrogen receptor (1986) (0)
- Serological identification of 2 cancer-associated autoantigens from patients with early breast cancer (2008) (0)
- Estrogen-induced mitogens in breast cancer and their prognostic value. (1989) (0)
- The Synergy of TwoOvarian Hormone-induced Enzymes in HumanMammary Carcinogenesis (0)
- [Effects and mechanism of action of antiestrogens in breast cancer]. (1983) (0)
- マンノース6‐りん酸(M6P)のホスホン酸類似体の合成及び生物活性 (1999) (0)
- [Interaction of androgens with uterine receptors]. (1976) (0)
- Cathepsin D Secreted by Breast Cancer Cells 52 , 000 r M Degradation of Extracellular Matrix with In Vitro Updated (2006) (0)
- [Comparative study of the behavior of an anti-estrogen and estradiol in uterine cells]. (1973) (0)
- Aspartic protease inhibitors: synthesis of a radiolabelled fatty acid linked pepstatin (1997) (0)
- Hyper-expression of cathepsin D in breast cancer. Possible consequences in tumour invasion. (1990) (0)
- Correlation between Mannose-6-phosphate/IGFII Levels by in Situ Hybridization in Benign and Malignant Mammary Tumors1 (2006) (0)
- The Synergy of Two Ovarian Hormone-induced Enzymes in Human Mammary Carcinogenesis (2008) (0)
- [Steroid receptors and endocrine control of breast tumors]. (1977) (0)
- The Dual Role of Estrogens and Cathepsin D in Invasion and Metastasis (2001) (0)
- Immunostaining of oestrogen-regulated proteins on paraffin sections of premalignant diseases and in situ carcinomas (1998) (0)
- 12 Expression of Estrogen Receptors a and b in Early Steps of Human Breast Carcinogenesis (0)
- Comparison of the anti-proliferative effects of a progestin, R5020, and an anti-progestin RU 486, in human breast cancer cell lines (1987) (0)
- The secretion of pro cathepsin d and other lysosomal enzymes in estrogen treated mcf7 cells involves the saturation of the mannose 6 phosphate receptor (1990) (0)
- [Estrogen receptors and nuclear translocation in C3H independent mouse mammary tumors (author's transl)]. (1977) (0)
- [Oestrogen-induced proteins in breast cancer (author's transl)]. (1981) (0)
- [Steroid receptors in human pathology. Foreword (author's transl)]. (1981) (0)
This paper list is powered by the following services:
